APA (7th ed.) Citation

Silva, S. B., Wada, D. T., Dessotte, L. U., Wada, L. S., Faccio, A. A., & Cipriano, F. G. (2026). Rethinking Invasive Mediastinal Staging in the Era of Neoadjuvant Immune‐Checkpoint Inhibitors. Thoracic Cancer, 17(9), 1. https://doi.org/10.1111/1759-7714.70292

Chicago Style (17th ed.) Citation

Silva, Saulo Brito, Danilo Tadao Wada, Lycio Umeda Dessotte, Li Siyuan Wada, Adilson Aparecido Faccio, and Federico Garcia Cipriano. "Rethinking Invasive Mediastinal Staging in the Era of Neoadjuvant Immune‐Checkpoint Inhibitors." Thoracic Cancer 17, no. 9 (2026): 1. https://doi.org/10.1111/1759-7714.70292.

MLA (9th ed.) Citation

Silva, Saulo Brito, et al. "Rethinking Invasive Mediastinal Staging in the Era of Neoadjuvant Immune‐Checkpoint Inhibitors." Thoracic Cancer, vol. 17, no. 9, 2026, p. 1, https://doi.org/10.1111/1759-7714.70292.